Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Crémieux, Anne Claude ^a,b   Dumitrescu, Oana ^c   Lina, Gerard ^c   Vallee, Christian ^a   Côté, Jean François ^d   Muffat Joly, Martine ^e   Lilin, Thomas ^f   Etienne, Jerome ^c   Vandenesch, François ^c   Saleh Mghir, Azzam ^b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e INSERM   (France)

^f ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PANTON VALENTINE LEUKOCIDIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE FACTOR;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BONE DEFORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; INOCULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSCLE DISEASE; MYOSITIS; NONHUMAN; OSTEOMYELITIS; PATHOGENESIS; PROTEIN BLOOD LEVEL; RABBIT; ANIMAL; BONE; CHEMISTRY; DISEASE MODEL; FEMALE; HUMAN; METABOLISM; MICROBIOLOGY; MOUSE; NEUTROPHIL; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL TOXINS; BONE AND BONES; C-REACTIVE PROTEIN; DISEASE MODELS, ANIMAL; EXOTOXINS; FEMALE; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; NEUTROPHILS; OSTEOMYELITIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 70349744042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007204     Document Type: Article

References (31)

1. Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, et al. (2007) Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 13: 594-600.
2. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, et al. (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128-1132.
3. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753-759.
4. Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, et al. (2007) Factors associated with the high fatality rate of Panton Valentine Leukocidin associated Staphylococcus aureus necrotising pneumonia. Clin Infect Dis 45: 315-321.
5. Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, et al. (2007) Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 26: 1042-1048.
6. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, et al. (2006) Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144: 309-317.
7. Gonzalez BE, Martinez-Aguilar G, Hulten KG, Hammerman WA, Coss-Bu J, et al. (2005) Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115: 642-648.
8. (2007) Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 56: 325-329.
9. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE (2009) Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis 49: 65-71.
10. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, et al. (2007) Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315: 1130-1133.
11. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR (2008) Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 198: 1166-1170.
12. Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, et al. (2008) Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 3: e3198.
13. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, et al. (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194: 1761-1770.
14. Chambers HF (2009) Pathogenesis of staphylococcal infection: a manner of expression. J Infect Dis 199: 291-293.
15. Waldvogel FA, Medoff G, Swartz MN (1970) Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med 282: 316-322.
16. Panton NP, Valentine FCO (1932) Staphylococcal toxin. Lancet 222: 506-508.
17. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, et al. (2004) Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 23: 701-706.
18. Bocchini CE, Hulten KG, Mason EO Jr, Gonzalez BE, Hammerman WA, et al. (2006) Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117: 433-440.
19. Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, et al. (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15: 156-164.
20. Szmigielski S, Jeljaszewicz J, Wilczynski J, Korbecki M (1966) Reaction of rabbit leucocytes to staphylococcal (Panton-Valentine) leucocidin in vivo. J Pathol Bacteriol 91: 599-604.
21. Badiou C, Dumitrescu O, Croze M, Gillet Y, Dohin B, et al. (2008) Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses. Clin Microbiol Infect 14: 1180-1183.
22. Norden CW (1970) Experimental osteomyelitis. I. A description of the model. J Infect Dis 122: 410-418.
23. (2001) 2000 Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 218: 669-696.
24. Croze M, Dauwalder O, Dumitrescu O, Badiou C, Gillet Y, et al. (2009) Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection. Clin Microbiol Infect 15: 144-148.
25. Valentine FCO, Butler ECB (1939) Specific immunity in acute staphylococcal osteomyelitis. Lancet 1: 973-978.
26. Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, et al. (2005) Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115: 3117-3127.
27. Brown EL, Bowden MG, Bryson RS, Hulten KG, Bordt AS, et al. (2009) Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol 16: 139-141.
28. Cremieux AC, Carbon C (1997) Experimental models of bone and prosthetic joint infections. Clin Infect Dis 25: 1295-1302.
29. Volk A, Cremieux AC, Belmatoug N, Vallois JM, Pocidalo JJ, et al. (1994) Evaluation of a rabbit model for osteomyelitis by high field, high resolution imaging using the chemical-shift-specific-slice-selection technique. Magn Reson Imaging 12: 1039-1046.
30. Scheman L, Janota M, Lewin P (1941) The production of experimental osteomyelitis: preliminary report. JAMA 117: 1525-1529.
31. Whalen JL, Fitzgerald RH Jr, Morrissy RT (1988) A histological study of acute hematogenous osteomyelitis following physeal injuries in rabbits. J Bone Joint Surg Am 70: 1383-1392.